歐盟對中國電動車展開調查 「蔚小理」ADR盤前跌1.7%至3%
歐盟宣布對中國電動車展開調查,「蔚小理」美國預託證券(ADR)盤前交易時段全面走低。小鵬(XPEV.US)盤前跌3%,報18.09美元;蔚來(NIO.US)盤前跌2.3%,報10.33美元;理想(LI.US)盤前跌1.7%,報40美元。
歐盟委員會主席馮德萊恩宣布,正在對中國電動車補貼展開調查,稱目前全球市場正充斥著廉價的中國電動車,認為中國通過巨額國家補貼來人為地壓低售價以扭曲歐盟市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.